Who are Bowel preparation for colonoscopy's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Pizensy, Halflytely, Miralax, Cephulac, Colace, Milk of Magnesia.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/bowel-preparation-for-colonoscopy.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-14 · How we verify

Bowel preparation for colonoscopy — Competitive Intelligence Brief

Bowel preparation for colonoscopy (Bowel preparation for colonoscopy) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Laxative. Area: Gastroenterology.

phase 2 Laxative Gastroenterology Small molecule Live · refreshed every 30 min

Target snapshot

Bowel preparation for colonoscopy (Bowel preparation for colonoscopy) — Manuel Hernandez-Guerra, MD. This drug works by inducing bowel movements and emptying the colon of stool and gas.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Bowel preparation for colonoscopy TARGET	Bowel preparation for colonoscopy	Manuel Hernandez-Guerra, MD	phase 2	Laxative
Pizensy	LACTITOL	Braintree Labs	marketed	Osmotic Laxative		2020-01-01
Halflytely	BISACODYL	Braintree	marketed	Stimulant Laxative [EPC]	Kappa-type opioid receptor	2004-01-01
Miralax	Macrogol	Braintree	marketed	Osmotic Laxative [EPC]		1984-01-01
Cephulac	LACTULOSE	Sanwa Kagaku Kenkyusho Co., Ltd.	marketed	Osmotic Laxative [EPC]		1976-01-01
Colace	docusate sodium	Generic (multiple manufacturers)	marketed	Stool softener (surfactant laxative)	N/A (surfactant mechanism)	1955-01-01
Milk of Magnesia	magnesium hydroxide	Generic (multiple manufacturers)	marketed	Osmotic laxative, Antacid	Gastric acid (direct neutralization) + osmotic effect in intestine	1880-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

2032-03-09 — Miralax · 10780112 · US
2032-03-09 — Miralax · 11529368 · US
2032-03-09 — Miralax · 10792306 · US
2032-03-25 — Miralax · 10646512 · US
2032-08-11 — Miralax · 9592252 · US
2033-09-10 — Miralax · 9326969 · US
2033-09-10 — Miralax · 9707297 · US
2033-09-10 — Miralax · 8999313 · US
2033-09-10 — Miralax · 10918723 · US
2033-09-10 — Miralax · 10016504 · US

Sponsor landscape (Laxative class)

Manuel Hernandez-Guerra, MD · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Bowel preparation for colonoscopy — Competitive Intelligence Brief. https://druglandscape.com/ci/bowel-preparation-for-colonoscopy. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab